Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C.

Cancers (Basel). 2018 Oct 5;10(10). pii: E372. doi: 10.3390/cancers10100372.

2.

Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.

Bräutigam E, Lampl C, Track C, Nieder C, Pichler J, Hammer J, Geinitz H.

Clin Transl Oncol. 2018 Oct 3. doi: 10.1007/s12094-018-1957-6. [Epub ahead of print]

PMID:
30284233
3.

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.

Brandes AA, Gil-Gil M, Saran F, Carpentier AF, Nowak AK, Mason W, Zagonel V, Dubois F, Finocchiaro G, Fountzilas G, Cernea DM, Chinot O, Anghel R, Ghiringhelli F, Beauchesne P, Lombardi G, Franceschi E, Makrutzki M, Mpofu C, Urban HJ, Pichler J.

Oncologist. 2018 Sep 28. pii: theoncologist.2018-0290. doi: 10.1634/theoncologist.2018-0290. [Epub ahead of print]

PMID:
30266892
4.

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.

Schneider AM, Weghuber D, Hetzer B, Entenmann A, Müller T, Zimmermann G, Schütz S, Huber WD, Pichler J.

BMC Gastroenterol. 2018 Sep 15;18(1):140. doi: 10.1186/s12876-018-0868-x.

5.

TLR9-mediated activation of dendritic cells by CD32 targeting for the generation of highly immunostimulatory vaccines.

Sepulveda-Toepfer JA, Pichler J, Fink K, Sevo M, Wildburger S, Mudde-Boer LC, Taus C, Mudde GC.

Hum Vaccin Immunother. 2018 Aug 29:1-10. doi: 10.1080/21645515.2018.1514223. [Epub ahead of print]

PMID:
30156957
6.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Furtner J, Sheffield NC, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Mahdy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C.

Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.

PMID:
30150718
7.

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.

Spiegl-Kreinecker S, Lötsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W.

Neuro Oncol. 2018 Nov 12;20(12):1584-1593. doi: 10.1093/neuonc/noy104.

PMID:
30010853
8.

Assessment of endothelial cell function and physiological microcirculatory reserve by video microscopy using a topical acetylcholine and nitroglycerin challenge.

Hilty MP, Pichler J, Ergin B, Hefti U, Merz TM, Ince C, Maggiorini M.

Intensive Care Med Exp. 2017 Dec;5(1):26. doi: 10.1186/s40635-017-0139-0. Epub 2017 May 18.

9.

Chylothorax in thyroid surgery: a very rare case and systematic review of the literature.

Merki V, Pichler J, Giger R, Mantokoudis G.

J Otolaryngol Head Neck Surg. 2016 Oct 18;45(1):52. Review.

10.

Reduced risk of pulmonary emboli in children treated with long-term parenteral nutrition.

Pichler J, Biassoni L, Easty M, Irastorza I, Hill S.

Clin Nutr. 2016 Dec;35(6):1406-1413. doi: 10.1016/j.clnu.2016.03.016. Epub 2016 Mar 31.

PMID:
27086197
11.

Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.

Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M.

Pediatr Res. 2016 Jun;79(6):895-901. doi: 10.1038/pr.2016.27. Epub 2016 Feb 16.

PMID:
26882369
12.

Microarray profiling of preselected CHO host cell subclones identifies gene expression patterns associated with increased production capacity.

Harreither E, Hackl M, Pichler J, Shridhar S, Auer N, Łabaj PP, Scheideler M, Karbiener M, Grillari J, Kreil DP, Borth N.

Biotechnol J. 2015 Oct;10(10):1625-38. doi: 10.1002/biot.201400857. Epub 2015 Sep 23.

PMID:
26315449
13.

Overexpression of Hsp70 confers cytoprotection during gliadin exposure in Caco-2 cells.

Bidmon-Fliegenschnee B, Lederhuber HCh, Csaicsich D, Pichler J, Herzog R, Memaran-Dadgar N, Huber WD, Aufricht C, Kratochwill K.

Pediatr Res. 2015 Oct;78(4):358-64. doi: 10.1038/pr.2015.112. Epub 2015 Jun 18.

PMID:
26086640
14.

Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.

Pichler J, Huber WD, Aufricht C, Bidmon-Fliegenschnee B.

World J Gastroenterol. 2015 Jun 7;21(21):6613-20. doi: 10.3748/wjg.v21.i21.6613.

15.

Nutritional status in children with Shwachman-diamond syndrome.

Pichler J, Meyer R, Köglmeier J, Ancliff P, Shah N.

Pancreas. 2015 May;44(4):590-5. doi: 10.1097/MPA.0000000000000291.

PMID:
25742431
16.

Prevalence of Gallstones Compared in Children With Different Intravenous Lipids.

Pichler J, Watson T, McHugh K, Hill S.

J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):253-9. doi: 10.1097/MPG.0000000000000761.

PMID:
25688480
17.

Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.

Spiegl-Kreinecker S, Lötsch D, Ghanim B, Pirker C, Mohr T, Laaber M, Weis S, Olschowski A, Webersinke G, Pichler J, Berger W.

Neuro Oncol. 2015 Sep;17(9):1231-40. doi: 10.1093/neuonc/nov010. Epub 2015 Feb 13.

18.

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.

Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bähr O, Platten M, Tonn JC, Schlegel U, Marosi C, Goldbrunner R, Stupp R, Homicsko K, Pichler J, Nikkhah G, Meixensberger J, Vajkoczy P, Kollias S, Hüsing J, Reifenberger G, Wick W; DIRECTOR Study Group.

Clin Cancer Res. 2015 May 1;21(9):2057-64. doi: 10.1158/1078-0432.CCR-14-2737. Epub 2015 Feb 5.

19.

A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.

Wick W, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, Schliesser MG, von Deimling A, Pichler J, Vetlova E, Harting I, Debus J, Hartmann C, Kunz C, Platten M, Bendszus M, Combs SE.

Clin Cancer Res. 2014 Dec 15;20(24):6304-13. doi: 10.1158/1078-0432.CCR-14-0951-T. Epub 2014 Oct 22.

20.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Pichler J, Hutterer M, Melchardt T, Bartsch R, Zielinski CC, Birner P, Preusser M.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):e41-55. doi: 10.1111/nan.12185.

PMID:
25256708

Supplemental Content

Loading ...
Support Center